BlogFeaturedViral vaccinesViral vectors Taking your adenoviral vector product from R&D to the clinic Adenoviruses have been shown to be very effective vehicles for delivering genetic material to cells…Claire Otjes25 April 2022
FeaturedNews Batavia wins 2022 ViE Award for Best Process Development Washington, April 20, 2022 - Batavia Biosciences was honored this week during the Vaccine Industry…Claire Otjes20 April 2022
Scientific publication Modeling long-term stability profiles of novel rotavirus vaccine in liquid formulations We are proud to announce a fourth publication coming from our rotavirus vaccine project, funded…Claire Otjes28 January 2022
BlogViral vectors Do fixed-bed bioreactors provide a solution to viral vector shortage? Written by expert: Yang, Bioprocess Scientist In 2017, the New York Times wrote an article…Claire Otjes27 January 2020
BlogProteins antibodies Developing stable cell lines for difficult to express proteins: laronidase example Written by expert: Wilfried, Director of Science and Innovation For protein-based biopharmaceuticals, product yield from…Claire Otjes26 November 2019
BlogViral vaccines Challenges in virus-based manufacturing in GMP Written by expert: Marije, GMP Scientist Many customers want to know how much time it…Claire Otjes21 October 2019
Blog Analytical assay development: go ALL the way Written by expert: Gert, Associate Director Assays The truth is; the accuracy and robustness of…Claire Otjes8 July 2019
BlogViral vaccinesViral vectors Latest advancements in bioprocess intensification for efficient biopharmaceutical production Written by expert: Ahd, Director Project Management Current costs of biopharmaceutical manufacturing often prevent segments…Claire Otjes8 July 2019
BlogProteins antibodies Improved selection of protein-producing cell lines using a scale-down approach – a case study Written by expert: Alfred, Global Technical Sales Director The selection of stable protein producing cell…Claire Otjes1 April 2019
BlogViral vaccines Genetic stability studies: could process parameters change your virus? Written by expert: Monika, Associate Director Viral Vector Development Despite having very limited coding capacity, most…Claire Otjes28 January 2019